未找到相关数据
A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations.
被引：0
作者：
Choi, Moon Ki
Hong, Jung Yong
Chang, Won Jin
Kim, Moonjin
Kim, Sungmin
Jung, Hyun Ae
Lim, Sung Hee
Lee, Ji Yun
Do, Ingu
Chol, Yoon-La
Sun, Jong-Mu
Ahn, Jin Seok
Park, Kounchil
Ahn, Myung-Ju
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Pathol, Seoul, South Korea
[3] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pathol, Seoul, South Korea
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e19155
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19155
引用
收藏
页数：1
相关论文